How To Achieve Optimal Perioperative Glycemic Control In Patients With Diabetes
- Volume 19 - Issue 12 - December 2006
- 14532 reads
- 0 comments
1. Hoogwerf BJ. Perioperative management of diabetes mellitus: how should we act on the limited evidence? Cleve Clin J Med. Mar 2006;73 Suppl 1:S95-9.
2. Clark JDA, Currie J, Hartog M. Management of diabetes in surgery: a survey of current practice by anaesthetists. Diabet Med. 1992;9:271-274.
3. Hirsch IB, McGill JB, Cryer PE, et al. Perioperative management of surgical patients with diabetes mellitus. Anesthesiology. 1991;74:346-359.
4. Zaloya GP. Catecholamines in anesthetic and surgical stress. Int Anesthesiol Clin. 1988;26:187-198.
5. Werb MR, Zinman B, Teasdale SJ, Goldman BS, SKully HE, Marliss EB. Hormone and metabolic responses during coronary artery bypass surgery: role of infused glucose. J Clin Endocrinol Metab. 1989;69:1010-1018.
6. Monk TG, Mueller M, White PF. Treatment of stress response during balanced anesthesia. Anesthesiology. 1992;76:39-45.
7. Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A. Glucose Control Lowers the Risk of Wound Infection in Diabetics After Open Heart Operations. Ann Thorac Surg. 1997;63:356–61.
8. Furnary AP, Zerr KJ, Grunkemeier GL, et al: Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. 1999;67:352-362.
9. Hruska LA, Smith JM, Hendy MP, Fritz VL, McAdams S. Continuous Insulin Infusion Reduces Infectious Complications in Diabetics Following Coronary Surgery. J Card Surg. 2005;20:403-407.
10. Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ. May 1997;24;314(7093):1512-5.
11. Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, Floten HS, Starr A. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. May 2003;125(5):1007-21.
12. Vincent MA, Montagnani M, Quon MJ. Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium. Curr Diab Rep. Aug 2003;3(4):279-88.
13. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest. Sept 1994;94(3):1172-9.
14. Petrauskiene V, Falk M, Waernbaum I, Norberg M, Eriksson JW. The risk of venous thromboembolism is markedly elevated in patients with diabetes. Diabetologia. 2005;48: 1017–1021.
15. Butler SO, Btaiche IF, Alaniz C. Relationship between hyperglycemia and infection in critically ill patients. Pharmacotherapy. July 2005;25(7):963-76.
16. Bagdade JD, Stewart M, Walters E. Impaired granulocyte adherence: a reversible defect in host defense in patients with poorly controlled diabetes. Diabetes. 1978;27:677.
17. Marston WA, Dermagraft Diabetic Foot Ulcer Study Group. Risk Factors Associated with Healing Chronic Diabetic Foot Ulcers: The Importance of Hyperglycemia. Ostomy Wound Manag. Mar 2006;52(3):26-28.
18. The Diabetes Control and Complications Trial Research Group. The effect of intensive therapy of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329:977-986.
19. United Kingdom Prospective Diabetes Study Group (UKPDS). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet. 1998;352:853-857.
20. Jacober SJ, Sowers JR. An Update on Perioperative Management of Diabetes. Arch Intern Med. Nov 1999;159:2405-2411.
21. Rehman H, Mohammed K. Perioperative Management of Diabetic Patients. Current Surgery. Nov/Dec 2003;60(6): 607-611.